FIELD: medicine.
SUBSTANCE: inventions group relates to medicine, namely to endocrinology and psychiatry, and can be used to relieve symptoms of depression in an overweight or obese patient. The method and use of the invention include identifying a patient suffering from a major depressive disorder in which the patient is also overweight or obese and administering naltrexone and bupropion at 32 mg per day and 360 mg per day, respectively.
EFFECT: use of the inventions makes it possible to reduce the manifestation of symptoms of depression by at least 40% without increasing body weight.
30 cl, 1 tbl, 3 ex
